Results 41 to 50 of about 30,812 (239)

A New Trick for Percutaneous Tracheostomy in Children

, 2020
Objectives:Pediatric tracheostomy has undergone notable changes and percutaneous tracheostomy (PT) has taken place of surgical tracheostomy. The aim of this study is to show a facilitation in a previously described technique.Materials and Methods:A ...
Kutay Bahadır, Aydın Yağmurlu, Ufuk Ateş, Fırat Serttürk, Ahmet Murat Çakmak, Meltem Bingöl Koloğlu, Ergun Ergün, Gülnur Göllü, Hüseyin Dindar, Özlem Selvi Can   +9 more
core   +1 more source

Cost Effectiveness of Immediate Tracheostomy versus Early Tracheostomy in Decompressive Craniectomy Patients: A Retrospective Study [PDF]

, 2021
Cost Effectiveness of Immediate Tracheostomy versus Early Tracheostomy in Decompressive Craniectomy Patients: A Retrospective Study Dr. Hezry bin Abu Hasan ’, Dr. Sofan bin Zenian ’, Dr. Regunath Kandasamy 2, Prof. Dato’ Dr.
Hasan, Hezry Abu
core  

Tracheostomy timing and clinical outcomes in ventilated COVID-19 patients: a systematic review and meta-analysis

Critical Care, 2022
Background The association of tracheostomy timing and clinical outcomes in ventilated COVID-19 patients remains controversial. We performed a meta-analysis to evaluate the impact of early tracheostomy compared to late tracheostomy on COVID-19 patients ...
Yun Ji, Yumin Fang, Baoli Cheng, Libin Li, Xiangming Fang   +4 more
doaj   +1 more source

Early versus Late Tracheostomy for Intubated Patients in Intensive Care Units

Advanced Medical Journal, 2023
Background and objectives:Tracheostomy, is an integral component of the management plan for the critically ill patients admitted in the intensive care unit under endotracheal intubation.
Shkar Nazar Mohammed , Saleh Ahmed Tawfique, Hiwa Asaad Abdulkareem   +2 more
doaj   +1 more source

Early vs. Late Tracheostomy in Patients with Traumatic Brain Injury: Systematic Review and Meta-Analysis [PDF]

, 2021
Introduction. Tracheostomy can help weaning in long-term ventilated patients, reducing the duration of mechanical ventilation and intensive care unit length of stay, and decreasing complications from prolonged tracheal intubation.
Antonio Coviello, Giuseppe Servillo, Carmine Iacovazzo, Annachiara Marra, Maria Vargas, Pasquale Buonanno   +5 more
core   +2 more sources

One-stage tracheostomy during surgery reduced early pulmonary infection and mechanical ventilation length in complete CSCI patients

Frontiers in Surgery, 2023
ObjectiveComplete cervical spinal cord injury (CSCI) is a devastating injury that usually requires surgical treatment. Tracheostomy is an important supportive therapy for these patients.
Lin Sun, Lin Sun, Haoyu Feng, Haoyu Feng, Jun Mei, Jun Mei, Zhiqiang Wang, Zhiqiang Wang, Chen Deng, Chen Deng, Zhixin Qin, Zhixin Qin, Junqiao Lv, Junqiao Lv   +13 more
doaj   +1 more source

Changing Trends in Tracheostomy in a Critical Care Unit: A Study from a Tertiary Care Centre in Western India

Bengal Journal of Otolaryngology and Head Neck Surgery, 2022
Introduction Identification of newer trends in indications and timing of tracheostomy and their implication on the outcome of the patients in a critical care unit, based on observations recorded in patients from a tertiary care centre in Western ...
Shreha Pathak, Kinnari Rathod, Madhavi Raibagkar   +2 more
doaj   +3 more sources

Association of tracheostomy timing with outcomes following traumatic brain injury

Surgery Open Science
Introduction: The optimal timing for tracheostomy among patients with traumatic brain injury (TBI) remains controversial. Earlier tracheostomy is hypothesized to reduce sedation requirements and allow for earlier mobility.
Syed Shaheer Ali, Troy Coaston, Konmal Ali, Giselle Porter, Esteban Aguayo, Areti Tillou, Peyman Benharash, Galinos Barmparas   +7 more
doaj   +1 more source

Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24‐Month Follow‐Up From the Italian Registry

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane, Giorgia Coratti, Chiara Cutrì, Antonio Varone, Riccardo Masson, Adele D'Amico, Valeria Sansone, Sonia Messina, Federica Ricci, Chiara Ticci, Claudio Bruno, Caterina Agosto, Francesca Benedetti, Antonella Pini, Sabrina Siliquini, Massimiliano Filosto, Alberto Zambon, Ilaria Bitetti, Maria Rosaria Manna, Claudia Dosi, Riccardo Zanin, Stefano Parravicini, Roberto De Sanctis, Giulia Stanca, Michela Catteruccia, Michele Tosi, Irene Mizzoni, Emilio Albamonte, Valentina Franchino, Maria Sframeli, Ilaria Cavallina, Elena Procopio, Michele Sacchini, Simone Morando, Noemi Brolatti, Federica Trucco, Gaia Scarpini, Elena Briganti, Beatrice Berti, Concetta Palermo, Daniela Leone, Stefano C. Previtali, Eugenio Mercuri, the ITASMAC working group   +43 more
wiley   +1 more source

Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito, Kamal Benguerba, Ken Tsuchida, Kazushige Yazawa, Isao Tsumiyama, Hiromitsu Kayama, Sandra P. Reyna, Farid Khan, Richard S. Finkel   +8 more
wiley   +1 more source